drugset / Trial / NCT03728946

Interscalene Block With and Without Liposomal Bupivacaine in Shoulder Surgery

NCT03728946 ↗

RandomizedParallel-groupSingle-blindSupportive care

Summary

The purpose of this study is to examine the difference in perioperative pain after shoulder surgery with a standard bupivacaine nerve block compared to liposomal bupivacaine enhanced nerve block alone in TSA and ARCR. Data will be compared using VAS scores and opiate consumption between the two groups. The hypothesis of this study is that an interscalene nerve block with liposomal bupivacaine will decrease both postoperative VAS pain scores and total narcotic consumption when compared to a standard bupivacaine interscalene nerve block alone.

Timeline

Start
2018-11-21
Primary completion
2020-03-01
Completion
2020-03-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 15 ml Other

Indications